Clik here to view.
KYOCERA Honored by Japan’s METI for Aquala® Artificial Hip Joint Technology
KYOTO, Japan Kyocera Corporation (NYSE:KYO)(TOKYO:6971) today announced that its innovative Aquala technology received Japan’s “Prize of the Minister of Economy, Trade and Industry” during the 2018...
View ArticleClik here to view.
ImpediMed Vice President Dennis Schlaht Receives 2018 Advocate Award from...
SANTA MONICA, Calif. ImpediMed Limited (ASX: IPD), the global leader in the design and manufacture of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the...
View ArticleClik here to view.
AVITA Medical RECELL® Device Pivotal Trial Results in Second-Degree Burns...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) announced today that results from a pivotal clinical trial demonstrating the effectiveness and clinical benefits of...
View ArticleClik here to view.
SanBio: Summary of Procurement of Funds in the Current Fiscal Year
TOKYO The Group (SanBio Co., Ltd. and its subsidiary SanBio, Inc.) hereby announces procurement of funds totaling ¥11,000 million upon completion of exercise of share acquisition rights with an...
View ArticleClik here to view.
STAAR Surgical and Kobe Kanagawa Eye Clinic in Japan Announce Strategic...
MONROVIA, Calif. STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, and Kobe Kanagawa Eye Clinic...
View ArticleClik here to view.
AVITA Medical Announces Presentation of RECELL® Device Clinical Trial Results...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) announced today that results from two U.S. pivotal clinical trials and the U.S. Compassionate Use program...
View ArticleClik here to view.
Ligand Receives $47 Million from WuXi Biologics for Expansion of Worldwide...
SAN DIEGO Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces it has received $47 million as a result of signing an amendment relating to its OmniAb platform agreement with WuXi Biologics...
View ArticleClik here to view.
AVITA Medical Announces Acquisition of Manufacturing Facility to Support...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced that it has entered into an agreement to acquire a manufacturing facility to support the planned...
View ArticleClik here to view.
Alexion Submits Application for Approval of ALXN1210 as a Treatment for...
NEW HAVEN, Conn. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the submission of a Marketing Authorization Application to the European Medicines Agency (EMA) for ALXN1210, the...
View ArticleClik here to view.
阿联酋卫生部采用搭配Eve™的Masimo Rad-97™脉搏碳氧氧饱和度仪®实施全国性CCHD新生儿筛查项目
阿联酋迪拜 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，阿联酋(UAE)卫生部(MOHAP)正面向所有新生儿实施一项全国性危重型先天性心脏病(CCHD)筛查方案。作为该项目启动的一部分，MOHAP正在为5个酋长国覆盖50%的阿联酋人口的9家医院提供搭配Eve™ CCHD新生儿筛查应用的Masimo...
View ArticleClik here to view.
Daiichi Sankyo and Menarini Enter into Exclusive Licensing Agreement for...
SINGAPORE Singapore based A. Menarini Asia-Pacific Holdings Pte Ltd (“Menarini Asia-Pacific”) and Daiichi Sankyo Co., Ltd. (“Daiichi Sankyo”) have signed a multi-year exclusive licensing agreement...
View ArticleClik here to view.
Clik here to view.
Alteogen and Lynkogen Enter into an Exclusive Option Agreement to Develop...
DAEJEON, Korea & EAST WINDSOR, N.J. Alteogen Inc. (KOSDAQ:196170) and Lynkogen Inc. today announced that they have entered into an exclusive option agreement for the development of Alteogen’s...
View ArticleClik here to view.
New Study Investigates the Utility of Masimo ORi™ (Oxygen Reserve Index) in...
MORIOKA, Japan Masimo (NASDAQ: MASI) announced today the findings of a study in which researchers evaluated the ability of Masimo ORi™ (Oxygen Reserve Index) to detect declining blood oxygenation...
View ArticleClik here to view.
Toyoda Gosei and EBM Corporation Develop a Prototype “Super BEAT” Medical...
KIYOSU, Japan Toyoda Gosei Co., Ltd. and EBM Corporation1 have developed a prototype “Super BEAT” surgical training simulator that can reproduce the beating of the heart with extreme accuracy using...
View ArticleClik here to view.
Takeda Global Headquarters Grand Opening
OSAKA, Japan Takeda Pharmaceutical Company Limited, (“Takeda”) (TOKYO:4502) today held the grand opening of Takeda Global Headquarters. The building, completed in March 2018, will serve as Takeda’s...
View ArticleClik here to view.
「武田グローバル本社」のグランドオープンについて
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（東証：4502）は、本日、「武田グローバル本社」（所在地：東京都中央区日本橋本町）をグランドオープンしましたのでお知らせいたします。「武田グローバル本社」は、世界中で事業を展開する武田薬品のグローバル本社として本年3月に竣工しました。...
View ArticleClik here to view.
TRIGR Therapeutics and ABL Bio Announce Global Oncology Collaboration on...
IRVINE, Calif. TRIGR Therapeutics, a US-based Biopharmaceutical company, and ABL Bio Corporation, a South Korean biotechnology company, jointly announced today that it had entered into a binding...
View ArticleClik here to view.
Gore Announces First Commercial In-Human Use of GORE® TAG® Conformable...
FLAGSTAFF, Ariz. W. L. Gore & Associates, Inc. (Gore) today announced the first patient implant of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System after being included...
View ArticleClik here to view.
前立腺がんに対する新たな放射線治療 SpaceOAR®ハイドロゲルがついに日本で販売開始
東京 （ビジネスワイヤ） — オーグメニックス株式会社は、前立腺と直腸の間に留置する合成吸収性スペーサーであるSpaceOARハイドロゲルが保険収載され、前立腺がんの放射線治療を受ける全ての患者に使用できるようになったと発表しました。SpaceOARハイドロゲルは、前立腺がんに対する放射線治療を行う際に懸念される副作用の低減において臨床的な有用性が示されています。1,2...
View Article